Argus
•
Nov 06, 2026
Quest Diagnostics Incorporated: Raising price target
Summary
Quest Diagnostics is a provider of clinical diagnostic services that help to identify and treat disease and improve healthcare management. The company is based in Secaucus, New Jersey; it has 60,000 employees. The DGX shares are a component of the S&P 500.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
SMID November 2026 Pick List
Nov 06, 2026
•
CARR, CTVA, FLUT, AMCR, F, KHC, LVS, RIVN, O, BR, CRWV, Q, CTSH, LPLA, HONA, ON, PYPL, ZBH, RMD, BKR, OTIS, HSY, WSO, EXE, INVH, EIX, PCG, ALB, CPNG, MDLN
Analyst Report: Humana Inc.
Nov 06, 2026
•
HUM
Analyst Report: Becton, Dickinson and Company
Nov 06, 2026
•
BDX
Analyst Report: DaVita Inc.
Nov 06, 2026
•
DVA
Analyst Report: The Cigna Group
Nov 05, 2026
•
CI
Analyst Profile
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.
